Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19?

International journal of molecular sciences - 3 Jun 2022

Szyda Joanna, Dobosz Paula, Stojak Joanna, Sypniewski Mateusz, Suchocki Tomasz, Kotlarz Krzysztof, Mroczek Magdalena, Stępień Maria, Słomian Dawid, Butkiewicz Sławomir, Sztromwasser Paweł, Liu Jakub, Król Zbigniew J

Abstract excerpt

COVID-19 infections pose a serious global health concern so it is crucial to identify the biomarkers for the susceptibility to and resistance against this disease that could help in a rapid risk assessment and reliable decisions being made on patients' treatment and their potential hospitalisation. Several studies investigated the factors associated with severe COVID-19 outcomes that can be either environmental,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genome-Wide Association Study

Share to Immunity, Innate

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 35682950
DOI: 10.3390/ijms23116272
PMCID: PMC9181155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beyond GWAS-Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19?PMID 35682950Read ↗

A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality.Semantic proximity Read ↗

Host Genetic Factors for COVID-19 Severity and Outcome in Western Indian PopulationSemantic proximity Read ↗

First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome.Semantic proximity Read ↗

Exploration of causal relationship between transplant rejection and immune cells: A two-sample Mendelian randomization study.Semantic proximity Read ↗

Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactionsSemantic proximity Read ↗

Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19Semantic proximity Read ↗

The Genetic Interface of Immunity and COVID-19: Insights from a Two-Sample Mendelian Randomization ApproachSemantic proximity Read ↗

Shared genetic mechanism between type 2 diabetes and COVID-19 using pathway-based association analysisSemantic proximity Read ↗

Role of Potential COVID-19 Immune System Associated Genes and the Potential Pathways Linkage with Type-2 DiabetesSemantic proximity Read ↗

Single-cell transcriptome-wide Mendelian randomization and colocalization reveals immune-mediated regulatory mechanisms and drug targets for COVID-19Semantic proximity Read ↗

PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohort.Semantic proximity Read ↗

The Role of Immunogenetics in COVID-19.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.